Yuhong Mi

RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Hossein Ardeschir Ghofrani, Gérald Simonneau, Andrea Maria D’Armini et al. · The Lancet Respiratory Medicine · 2017 · 262 citations

Extracorporeal Membrane Oxygenation for Critically Ill Patients With 2009 Influenza A (H1N1)‐Related Acute Respiratory Distress Syndrome: Preliminary Experience From a Single Center

Xiaotong Hou, Limin Guo, Qingyuan Zhan et al. · Artificial Organs · 2012 · 34 citations

Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction

Kun Zhang, Xinchao Zhang, Yuhong Mi et al. · Chinese Medical Journal · 2013 · 33 citations · Full text

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Hossein Ardeschir Ghofrani, Gérald Simonneau, Andrea Maria D’Armini et al. · The Lancet Respiratory Medicine · 2024 · 31 citations

Thrombosis, Hypertension, Pulmonary Arterial Hypertension +9

Risk factors for noninvasive ventilation failure in patients with acute cardiogenic pulmonary edema: A prospective, observational cohort study

Zujin Luo, Fusheng Han, Hangyong He et al. · Journal of Critical Care · 2017 · 17 citations

Acute Lung Injury, Heart Failure, Pulmonary Care +11